Triflusal CAS:322-79-2

Triflusal is primarily used in the medical field as an antiplatelet and anti-inflammatory agent, making it valuable in the prevention and treatment of cardiovascular diseases. Its mechanism of action involves inhibiting platelet aggregation, which reduces the risk of thrombus formation and subsequently lowers the incidence of major cardiovascular events such as heart attacks and strokes. This makes Triflusal a critical therapeutic option for patients at risk of thrombosis. In addition to its antithrombotic properties, Triflusal also possesses analgesic and anti-inflammatory effects, which can be beneficial in managing pain and inflammation associated with various conditions. This dual-action capability allows it to be utilized not only in cardiovascular therapy but also in treating inflammatory disorders. Research continues to explore the potential of Triflusal in other therapeutic areas, including its role in neuroprotection and improving microcirculation. Ongoing studies are aimed at understanding its efficacy in combination therapies and assessing its long-term safety profile. As a result, Triflusal remains an important compound in pharmaceutical research, contributing to advancements in both cardiovascular and general health treatments.